KDM2A and breast cancer: Similarly, inhibition of the lysine demethylase 2A (KDM2A), which catalyzes the trimethylation of H3K36, sensitized breast cancer cells to cisplatin and blocked tumorsphere formation by inhibiting Notch [303].